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INTRODUCTION
 Stroke is a major public health problem all over the world. It plays an 
important role in the morbidity and mortality in late middle age and in the 
elderly. Stroke is the third most common cause of death in the world after 
coronary artery disease and cancer.  It  is the single most important case of 
severe  disability  and  also  the  most  common  life  threatening  neurological 
disease.
The burden of stroke is likely to increase substantially in the future 
because of the aging population. Apart from implementing effective stroke 
prevention  programs,  identification  of  factors  associated  with  more severe 
stroke may help to ease the burden of this coming epidemic.
Stroke is a heterogenous disease. Ischaemic and haemorrhagic strokes 
are the 2 main types of stroke, with very different pathogenesis and outcome. 
For  India,  community  surveys  have  shown,  a  crude  prevalence  rate  for 
hemiplegia is in the range of 200 per 1,00,000 persons, nearly 1.5% of all 
urban  hospital  admission,  4.5%  of  all  medical  and  around  20%  of 
neurological cases.  
Uric acid is  the most abundant aqueous antioxidant  in humans,  and 
contributes as much as two-thirds of all free radical scavenging capacity in 
plasma.  It  is  particularly  effective  in quenching  hydroxyl, superoxide  and 
peroxynitrite  radicals,  and  may  serve  a  protective  physiological  role  by 
preventing lipid peroxidation. In a variety of organs and vascular beds, local 
Uric acid concentrations increase during acute oxidative stress and ischaemia, 
and the increased concentrations might be a compensatory mechanism that 
confers protection against  increased free radical activity. In animal models, 
local Uric acid concentrations significantly increase in acute brain injury . For 
example,  in the  rat, middle  cerebral  artery  occlusion  causes  a  significant 
increase in cerebral Uric acid concentrations, which can persist for several 
days after the injury. These observations have prompted interest in the poten
Cerebral  infarction  initiates  a  complex cascade  of  metabolic events  in the 
surrounding tissue, and free-radical-mediated oxidative damage plays a key 
role in the pathogenesis of cerebral ischaemia. Free radicals are liberated from 
a variety of sources, including inflammatory cells, dysfunctional mitochondria 
and excitotoxic mechanisms stimulated by  increased glutamate and aspartate 
concentrations.  Hydroxyl  radicals  (formed  from  hydrogen peroxide) 
peroxynitrite  and  superoxide  are  powerful  radicals that  can  cause  lipid 
peroxidation,  a  self-propagating  chain reaction,  that  irreversibly  damages 
plasma  and  mitochondrial membranes.  Products  of  lipid  peroxidation,  for 
example  malondialdehyde, irreversibly  disrupt  enzymes,  receptors,  and 
membrane  transport mechanisms.  In acute  ischaemic  stroke, in vivo 
concentrations of  lipid  peroxidation  products  are  significantly  increased, 
arising from excess free radical activity. Plasma concentrations of cholesteryl 
ester  hydroperoxides  (CEOOH) are sensitive  and specific  markers  of  lipid 
peroxidation,  and  correlate positively  with  infarct  volume,  calculated  by 
computed  tomography, and  clinical  severity,  determined  by  the  National 
Institute of Health Stroke Scale. This emphasizes the role of oxidative stress in 
mediating  cerebral  ischaemic  tissue  damage,  and  is consistent  with  the 
observation  that  stroke volume  is  greater in patients  with  diminished 
antioxidant  capacity.  These  observations have  stimulated  interest  in the 
possibility that antioxidant treatments could offer benefits in acute ischaemic 
stroke, through their ability to defend against excess free radical activitytial 
impact  of  raised  local  Uric  acid  concentrations  in the  setting  of  acute 
ischaemic stroke.
Models of ischaemic neuronal  injury have shown that the addition of 
physiological  concentrations  of  Uric  acid  protects  hippocampal  neurons 
against  excitotoxic  and  metabolic  injury  in vitro.  The  effects of  raising 
circulating Uric acid concentrations, by direct administration, have also been 
studied  in vivo  in a rat model of acute ischaemic stroke, involving transient 
occlusion of one middle cerebral artery for 2 h. Administration of Uric acid, 
prior  to  ischaemia  or during  the  subsequent  reperfusion  period,  caused  a 
significant reduction  in infarct  volume,  and  led  to  improved  behavioural 
outcome at 24 hours. These findings suggest that early elevation of Uric acid, 
during  or  shortly  after  acute  ischaemic  stroke, could  confer  significant 
protection against neurological deficit. This is consistent with the protective 
effects of Uric acid observed in other models of cerebral diseases mediated by 
free radicals. 
A recent study lends support  to this  hypothesis  in a clinical setting. 
Serum Uric acid concentrations measured in 881 consecutive ischaemic stroke 
patients at the onset of ischaemic symptoms were found to correlate inversely 
with  early  neurological  impairment and  final  infarction  size  on  computed 
tomography or magnetic resonance imaging. Additionally,  serum Uric acid 
concentrations  were positively  associated  with  a  good  clinical  outcome  at 
hospital discharge  (Matthew  score  of  >75),  where  each  mg/dl  Uric  acid 
increase (equivalent  to  60  µmol/l;  reference  range  120–420 µmol/l)  was 
associated with a 12% increase  in the odds of a good outcome. Importantly, 
these relationships were independent of potential confounders, including age, 
diuretic  use,  renal function  or  the  presence  of  major  cardiovascular  risk 
factors. This is the first study to characterize the relationship between  serum 
UA concentration and neurological  severity  of acute ischaemic  stroke in a 
large series of patients. A potential limitation of this observational data is that 
it does not directly address the potential mechanisms by which Uric acid could 
improve stroke outcome, for example measurements of antioxidant capacity or 
oxidative stress. However, its findings support the potential benefits of raised 
Uric acid concentrations observed in vitro and in vivo experimental models. 
Despite  the  widely  held  view  that  elevated  serum Uric  acid 
concentrations confer  increased  risk  of  atherosclerotic  disease,  there  is  no 
compelling  biological  evidence  of  a  causal  link.  Free  radical activity  is 
characteristically  increased  in patients  with  any one  of  several  major 
cardiovascular  risk  factors,  and is  thought to  play  a  key  role  in the  early 
development  of  atherosclerosis. As  an  antioxidant,  Uric  acid  could  be 
expected to confer  protection against  free  radicals.  In the  context  of acute 
ischaemic  stroke, there is growing evidence to support a protective role for 
Uric  acid. This  underpins  the  importance  of  oxidative  stress  in the 
pathogenesis of  acute  stroke,  and  strengthens  the  rationale  for  further 
investigation of antioxidant treatments in this condition. The feasibility of Uric 
acid  administration  to  temporarily  increase  circulating  concentrations has 
recently been established, and might allow its potential therapeutic impact to 
be examined in a clinical setting. Ongoing basic research is likely to shed new 
light on the cardiovascular effects of Uric acid, and will hopefully allow the 
significance of serum concentrations to be interpreted more clearly.
This study is aimed at determining the correlation between the levels 
of serum uric acid and the prognosis of acute ischaemic stroke.
AIMS AND OBJECTIVES
1. To identify the role of serum uric acid in influencing the prognosis of 
acute  ischaemic stroke.
2. To  identify  whether  any  association  exists  between  age,  sex, 
hypertension,  diabetes,  dyslipidemia,  renal  parameters  and BMI and 
serum uric acid level.
REVIEW OF LITERATURE
DEFINITION OF STROKE
A stroke or cerebrovascular accident is a rapidly developing clinical 
symptoms and / or signs of focal and at times global (applied to patients in 
deep coma and to  those  with  subarachnoid  haemorrhage)  loss  of  cerebral 
function, with symptoms lasting for more than 24 hours or leading to death, 
with no apparent cause other than that of vascular origin.
ANATOMY OF CEREBRAL CIRCULATION
ARTERIES OF THE BRAIN
Two intemal carotid arteries and 2 vertebral arteries supply the brain. 
The  4  arteries  lie  within  the  substance  of  subarachnoid  space  and  their 
branches anastamose on the inferior surface of the brain to form the circle of 
Willis.
INTERNAL CAROTID ARTERY:
The left common carotid artery arises directly from the aorta and the 
right common carotid from the innominate artery. The internal carotid artery 
begins at the bifurcation of the common carotid artery. This ascends the neck 
and perforates the base of the skull by passing through the carotid canal of the 
temporal  bone.  The  artery  then  runs  horizontally  forward  through  the 
cavernous sinus and emerges on the medial side of the anterior clinoid process
by  perforating  the  duramater.  It  now  enters  the  subarachnoid  space  by 
piercing the arachnoid matter and turns posteriorly to the region of the medial 
end of the lateral cerebral sulcus. Here it divides into the anterior and middle 
cerebral arteries.
BRANCHES OF THE CEREBRAL PORTION
OPHTHALMIC ARTERY: The  ophthalmic  artery  arises  from  the 
internal carotid artery. It enters the orbit through the optic canal below and 
lateral to the optic nerve. It supplies the eye and other orbital structures and its 
terminal branches supply the frontal area of the scalp, the ethmoid and frontal 
sinuses and the dorsum of the nose.
POSTERIOR COMMUNICATING ARTERY:  The posterior communicating 
artery is a small vessel that originates from the internal carotid artery close to 
its terminal bifurcation The posterior communicating artery runs posteriorly 
above the oculomotor nerve to join the posterior cerebral artery to form part 
of the circle of Willis.
 
CHOROIDAL ARTERY:      The choroidal artery is a  small  branch that 
passes posteriorly, close to the optic tract, enters the inferior horn of lateral 
ventricle and ends in the choroids plexus. It gives off small branches to the 
crus cerebri, lateral geniculate body, optic tract and the internal capsule.
ANTERIOR CEREBRAL ARTERY: It  runs  forward  and  medially 
superior to the optic nerve and enters the longitudinal fissure of cerebrum. 
Here it joins with its fellow on the opposite side by means of the anterior 
communicating  artery.  It  curves  backward  over  the  corpus  callosum.  The 
cortical branches supply the whole of the surface of the cerebral cortex as far 
back as the parieto-occipital sulcus. They also supply a strip of cortex about 1 
inch  wide  on  the  adjoining  lateral  side.  The  anterior  cerebral  artery  thus 
supplies  the leg area of  the precentral  gyrus.  A group of  central  branches 
pierces the anterior perforated substance and helps to supply the parts of the 
lentiform and caudate nuclei and the internal capsule.
MIDDLE CEREBRAL ARTERY:      It is the largest branch of the internal 
carotid artery, runs laterally in the lateral cerebral sulcus. Cortical branches 
supply the entire lateral surface of the hemisphere, except for the narrow strip 
supplied  by  the  hemisphere,  which  are  supplied  by  the  anterior  cerebral 
artery, the occipital pole and the inferolateral surface of the posterior cerebral 
artery.
 This artery thus supplies the whole motor cortex except the leg area. 
Central  branches  enter  the  anterior  perforated  substance  and  supply  the 
lentiform and caudate nuclei and the intemal capsule.
VERTEBRAL ARTERY
The vertebral  artery,  a  branch of the  first  part  of  subclavian artery, 
ascends  in  the  neck  by  passing  through  the  foramina  in  the  transverse 
processes of the upper 6 cervical vertebrae. It  enters the skull through the 
foramen  magnum  and  pierces  the  duramater  and  arachnoid  to  enter  the 
subarachnoid  space.  It  then  passes  upward,  forward  and  medially  on  the 
medulla oblongata.  At the lower border of the pons,  it  joins vessel  of the 
opposite side to form the basilar aliery.
BRANCHES OF THE CRANIAL PORTION
MENINGIAL BRANCHES.
These are small branches and they supply the bone and dura and the 
posterior cranial fossa.
POSTERIOR SPINAL ARTERY
The posterior spinal artery may arise from the vertebral artery or the 
Posterior inferior cerebellar artery. It descends on the posterior surface of the
 
spinal cord close to the posterior roots of the spinal nerves. Radicular arteries 
that enter the vertebral canal through the intervertebral foramina reinforce the 
branches.
ANTERIOR SPINAL ARTERY
It is formed from a contributory branch from each vertebral artery near 
its  termination.  The  single  artery  descends  on  the  anterior  surface  of  the 
medulla oblongata and the spinal cord and is embedded in the piamater along 
the anterior median fissure. The radicular arteries that enter the vertebral canal 
through the vertebral foramen reinforce the artery.
POSTERIOR INFERIOR CEREBELLAR ARTERY
This largest branch of the vertebral artery passes on an irregular course 
between the medulla and cerebellum. It supplies the inferior surface of the 
vermis,  central  nuclei  of  cerebellum and the under surface of  the cerebral 
hemisphere. It also supplies the medulla oblongata and the choroidal plexus of
the fourth ventricle.
MEDULLARY ARTERIES
These  are  very  small  branches  that  are  distributed  to  the  medulla 
oblongata.
BASILAR ARTERY
The basilar  artery,  formed by  the  union of  the  2  vertebral  arteries, 
ascends in the groove on the anterior surface of the pons. At the upper border 
of the pons, it divides into 2 posterior cerebral arteries.
BRANCHES OF THE BASILAR ARTERY
PONTINE ARTERIES.
These are numerous small arteries that enter the substance of the pons.
LABRINTHINE ARTERY
This  is  a  long  narrow  artery  that  accompanies  the  facial  and  the 
Vestibulocochlear nerves into the internal acoustic meatus and supplies the 
internal  ear.  It  often  arises  as  a  branch  of  the  anterior  inferior  cerebellar 
artery.
ANTERIOR INFERIOR CEREBELLAR ARTERY
This artery passes posteriorly and laterally and supplies the anterior 
and inferior part of the cerebellum, a few branches pass to pons and upper 
part of the medulla.
 
SUPERIOR CEREBELLAR ARTERY
This  arises  close  to  the  termination  of  the  basilar  artery.  It  winds 
around  the  cerebral  peduncle  and  supplies  the  superior  surface  of  the 
cerebellum.  It  also  supplies  the  pons,  the  pineal  gland  and  the  superior 
medullary velum.
POSTERIOR CEREBRAL ARTERY
This curves laterally and backwards around the mid brain and is joined 
by the posterior communicating branch of the internal carotid artery. Cortical 
branches supply the inferolateral and medial surfaces of the temporal lobe and 
lateral and medial surfaces of the occipital lobe. Thus it supplies the occipital 
lobe.  Central  branches  pierce  the  brain  substance  and  supply  palis  of  the 
thalamus, the lentiform nucleus, the midbrain, the pineal gland and the medial 
geniculate body.  A choroidal branch enters  the inferior  horn of  the lateral 
ventricle and supplies the choroid plexus.
CIRCLE OF WILLS
The circle of Willis lies in the interpeduncular fossa at the base of the 
brain. It is formed by anastomosis between the two internal carotid arteries 
and  the  two  vertebral  arteries.  The  anterior  communicating,  the  anterior 
cerebral, internal carotid, posterior communicating, posterior cerebral, and the 
basilar arteries all contribute to the circle. The circle of Willis allows blood 
that  enters  either  by  the  internal  carotid  or  the  vertebral  arteries  to  be 
distributed to any part of either cerebral hemisphere. The cortical and central 
branches arise from the circle and supply the brain substance.
ARTERIES TO SPECIFIC BRAIN AREAS
Mainly the medial  and lateral  striate central  branches of the middle 
cerebral artery supply the corpus striatum and the internal capsule; the central 
branches of the anterior cerebral artery supply the remainder of the structures. 
The  posterior  cerebral,  posterior  communicating and basilar  arteries 
supply the thalamus. 
The posterior cerebral, superior cerebellar, and basilar arteries supply 
the mid brain. 
The basilar and anterior, inferior and superior cerebellar arteries supply 
the pons. 
The vertebral, anterior and posterior spinal, posterior inferior cerebellar 
and basilar arteries supply the medulla oblongata.
VEINS OF THE BRAIN
EXTERNAL CEREBRAL VEINS
The superior cerebral veins pass upward over the lateral surface of the 
cerebral hemisphere and empty into the superior sagittal sinus. The superficial 
middle cerebral veins drain the lateral surface of the cerebral hemisphere; it 
runs inferiorly in the lateral sulcus and empties into the cavernous sinus. The 
deep  middle  cerebral  vein  drains  the  insula  and  is  joined  by  the  anterior 
cerebral  vein  and  striate  veins  to  form the  basilar  vein.  The  basilar  vein 
ultimately joins the great cerebral vein, which in turn drains into the straight 
sinus.
INTERNAL CEREBRAL VEINS.
There are two internal veins, and the union of the thalamo striate vein 
and the choroidal vein at the interventricular foramen forms them. These two 
veins form the great cerebral vein that drains into the straight sinus.
EPIDEMIOLOGY OF CEREBROVASCULAR DISEASES IN INDIA
The  burden  of  stroke  on  the  community  is  best  reflected  by  its 
incidence.  Two  incidence  studies  conducted  in  the  late  sixties  and  early 
seventies have been reported. The first population-based study was conducted 
in Vellore in two phases. In the first  phase (1968 - 1969) a population of 
2,58,576 in and around Vellore was surveyed to detect cases of hemiplegia. In 
the second phase (1969 - 197 I) the population was kept under surveillance 
for two years and attempts were made to record all cases of hemiplegia. An 
incidence of 13/1,00,000 population per year was observed. The second study 
was carried out as a part of WHO collaborative study in Rohtak. Halyana 
between 1971- 1974. An annual incidence of : 33/1,00,000 population was 
noted. 
In India prevalence vary from region to region. Vellore, Gowribidanur, 
and  Rohtak  had  a  prevalence  of  40-60/1,00,000  population,  whereas  the 
Eastern part of India showed a prevalence of 100-270/1,00,000. 
Stroke incidence varies among different countries.  In WHO Monica 
project has shown high prevalence and mortality among Finnish population. 
According  to  this  study  incidence  of  stroke  varies  from  100/1,00,000  in 
Germany to 290/1,00,000 population of men in Finland.
 
CLASSIFICATION OF STROKE
Stroke can be classified in various ways. Suggested classification of 
stroke
1. ANATOMICAL CLASSIFICATION.
A. By vascular supply
a. Carotid
b. Vertebrobasilar
B. By location
a. Supratentorial
i. Lobar
ii. Ganglionic /thalamic
b. lnfratentorial
i. Cerebel1ar
ii. Brain stern
 2. ETIOLOGICAL CLASSIFICATION.
A. By result.
a. Cerebral infarct
b. Cerebral haemorrhage
i. Parenchyma
ii. Subarachnoid.
RISK FACTORS FOR STROKE
They can be grouped into  modifiable  and non-modifiable.  Some of 
them are as follows. 
 Age
The incidence of stroke increases dramatically with advancing age, and 
increasing age is an important risk factor for stroke.
 Sex
Male sex is associated with increased risk of stroke.
 
 Race
The rate of cerebral infraction is higher in blacks than in whites. This 
could  be  partially  explained  by  the  higher  prevalence  of  diabetes  and 
hypertension in them.
 Blood pressure
Hypertension  is  the  single  most  dominant  risk  factor  for  both 
ischaemic  and  hemorrhagic  stroke.  Hypertension  predisposes  to  ischaemic 
stroke by aggravating atherosclerosis. In India, one ICMR multicentric stroke 
study  on  risk  factors  found  hypertension,  smoking,  diabetes  and  low 
haemoglobin  as  risk  factors.  According  to  them  40%  of  stroke  can  be 
attributed to systolic blood pressure more than 140 mm of mercury. Eastern 
stroke  and  coronary  heart  disease  collaborative  research  found  that  blood 
pressure is an important risk factor in eastern Asian populations. They found 
that  3mm of Hg reduction in  diastolic blood pressure should decrease the 
number  of  stroke  by  about  a  third.  The  SHEP  study  has  shown  a  36% 
reduction in non-fatal stroke events over 5 years in the age group 60 years and 
above with isolated systolic hypertension treated with active medication.
 
 Diabetes Mellitus
Diabetes mellitus increases the risk of cerebrovascular disease 2 – 4 
fold compared with risk in nondiabetics. Stroke secondary to diabetes may be 
caused by cerebrovascular atherosclerosis, cardiac embolism, and rheological 
abnormalities. Diabetic patients with retinopathy and autonomic neuropathy 
are particularly at high risk for atherosclerosis.
 Cardiovascular diseases
Angina or myocardial infarction is clearly associated with stroke. ECG 
abnormalities  reflecting  hypertension  and  coronary  artery  disease  are  risk 
factors for stroke. Rheumatic heart disease and cardiac failure are other risk 
factors.
 Claudication
Claudication is a high risk factor for both myocardial infarction and 
stroke, presumably reflecting atheromatous disease in different parts of the 
circulation.
 
 Cigarette smoking
The relative risk is about 1.5. There is a dose dependent relationship 
between smoking and stroke. Cigarette smoking is a factor both in men and 
women. ICMR has shown that smoking is a risk factor both in the young and 
the elderly.
 Atrial fibrillation
Most frequent cardiac source of embolism to brain is atrial fibrillation 
either  rheumatic  or  non  rheumatic.  Atrial  fibrillation  is  associated  with 
increased risk for stroke accounting for 6 -24 % of all ischaemic strokes. 
 Carotid artery disease
Asymptomatic carotid artery disease less than 75% carries a stroke risk 
of  1.3%  annually.  With  stenosis  greater  than  75%  combined  transient 
ischaemic  attack  and  stroke  rate  is  10.5%  per  year.  Carotid  and 
supraclavicular  arterial  bruit  are  strongly  related  to  stenosis  of  underlying 
arteries.
 Transient ischemic attacks
A TIA patient has an excess risk of stroke by about 5 - 10 times greater
than a non TIA patient.
 
 Lipid abnormalities
Increasing levels of total plasma cholesterol, LDL and decreased levels
of HDL are strong risk factors for coronary artery disease than stroke. In a 
study conducted in NIMHANS they found that low HDL cholesterol is a risk 
factor in stroke group among various lipid fractions. Lipoprotein 'a' has been 
found to be an independent risk factor for stroke. 
 
 Other risk factors 
Abdominal  obesity,  plasma  fibrinogen,  homocysteine,  dietary 
measures,  snoring,  cornel  arcus,  psychological  factors,  diagonal  ear  lobe 
crease,  physical  inactivity,  maternal  history  of  stroke,  left  ventricular 
hypertrophy,  peripheral  vascular  disease,  alcohol  consumption,  oral 
contraceptives, plasma factor seven factor coagulant activity, hematocrit etc 
are some of the other risk factors.
PATHOPHYSIOLOGY OF ACUTE ISCHEMIC STROKE:
Cerebral  infarction  basically  comprises  two  pathophysiological 
processes.
1. A  loss  of  supply  of  oxygen  and  glucose  secondary  to  vascular 
occlusion.
2. An array of changes in cellular metabolism consequent to the collapse 
of  energy  producing  processes,  with  a  disintegration  of  cell 
membranes.
Normal  cerebral  blood  flow  at  rest  in  normal  adult  brain  is 
55ml/l00g/minute.  When  the  blood  flow  decreases  to  18ml/100g/mt  brain 
reaches  the  threshold  for  electrical  failure.  When  blood  decreases  to 
8ml/100g/mt cell death can result. These thresholds mark the upper and lower 
limits for the ischaemic penumbra. Ischaemic penumbra is the condition of 
the ischaemic brain between these 2 flow threshold in which there are some 
neurons that are functionally silent but are structurally intact and potentially 
salvageable. 
The recognition of penumbra has focused attention on the development 
of  treatment  to  minimize  or  to  even  reverse  the  damage  effects  of  the 
ischaemic  brain  by  drugs  when  started  within  a  short  period  after  the 
occlusion (therapeutic window).
PET studies have detected penumbral tissues lip to 72 hours post stroke. It 
may comprise up to 50% of final volume of infarction up to 17 hours after 
ischaemic  insult  and  the  out  come  of  stroke  patients  depend  upon  this 
proportion.
 
Ischaemia impairs cellular energy production and depletion of ATP, which 
is followed by a failure of ATP dependent ion transport system leading to 
cellular efflux of potassium and influx of sodium and water. This ischaemic 
depolarization causes presynaptic voltage sensitive calcium channels to open 
and allow calcium to enter the cell.  Intracellular calcium stimulates neural 
transmitters,  most  notably  excitatory  amino  acid  glutamate.  Extra  cellular 
glutamate  then  activates  2  postsynaptic  receptors  NMDA  receptor  and 
AMPA  receptors.  Massive  release  of  glutamate  causes  depolarization  of 
adjacent neurons, triggering further neurotransmitter release increasing their 
energy requirement and tripping them into energy failure. This is the basis for 
the so-called excitotoxic cell injury. Intracellular calcium triggers activation 
of enzymes, which affects the structure and function of cellular constituents. 
Stimulation  of  phospholipase  leads  to  an  inflammatory  reaction  through 
leucotriene production and stimulation of NO synthase, which causes build up 
of nitric oxide and free radicals. 
CLINICAL FEATURES OF STROKE.
It  depends upon the  site  of  lesion and type of  stroke,  ischaemic or 
hemorrhagic. Distinction between types of stroke is possible by history taking 
physical examination and investigation.
 
CLINICAL MAINFESTATIONS OF ISCHAEMIC STROKE
The  typical  ischaemic stroke  presents  with  abrupt  onset  of  focal 
neurological deficit and is characterized clinically by the mode of onset and 
subsequent course. 
A transient  ischaemic  attack is  arbitrarily  defined as  a  neurological 
deficit lasting less than 24 hours (usually 5-20 minutes). It often portends an 
impending  stroke.  The  pathophysiological  mechanisms for  TIA are  a  low 
flow in an artery due to a tight stenosis or occlusion or an embolism. 
A  completed  stroke  or  cerebral  infarction  typically  evolves  into 
maximum deficit in a few hours. It is sometimes heralded by TIA's. 
In  stroke  in  evolution  the  focal  ischaemia  worsens  from minute  to 
minute or hour to hour. There are usually stepwise incremental increases in 
neurological deficit occuring over several hours. 
The commonest sites of affection are
a. The origin of the ICA within its first 2cms
b. Siphon of ICA
c. Proximal segments of MCA and ACA
 Occlusion  of  ICA -  Patient  may  have  amaurosis  fugax  before  the 
occurrence of contralateral hemiparesis.
 Occlusion  of  MCA  stem -  Resulting  in  contralateral  hemiplegia, 
hemianaesthesia and global aphasia (dominant), apraxia and anosognosia 
(nondominant).
 Occlusion  of  inferior  division  MCA -  Wernickes  aphasia  without 
weakness often with superior quadrantanopia. If nondominant hemisphere, 
hemi neglect and spatial agnosia.
 Occlusion of ACA- Occlusion of Precommunal segment is well tolerated 
because of collateral flow. If both post communal segments arise from a 
single  ACA patient  suffers  profound abulia  (delayed motor  and verbal 
response), bilateral pyramidal signs and paraplegia. 
 Occlusion of PCA- Occlusion of PCA causes serious neurological deficits 
as  important  structure  are  involved  (brain  stem).  Thalamic  syndrome, 
Thalamoperforate syndrome, Weber's syndrome are some of the known 
syndromes.
 Vertebral artery and posterior inferior cerebellar artery lesions - This 
includes the well-known Lateral medullary syndrome. Medial medullary 
syndrome causes 12th  nerve lesion and contra lateral hemiplegia.
 Basilar artery- Complete basilar syndrome results in bilateral long tract 
signs  with  variable  cerebellar,  cranial  nerves  and  other  segmental 
abnormalities of brain stem.
 Occlusion  of  Superior  cerebellar  artery  - Ipsilateral  cerebellar  ataxia, 
contralateral hemianaesthesia, ipsilateral Horner's etc.
 Occlusion of Anterior inferior cerebellar artery - Ipsilateral  cerebellar 
ataxia, Ipsilateral Horners syndrome, conjugate gaze palsy, contra lateral 
loss of pain temperature etc.
DIAGNOSIS OF STROKE SUBTYPE USING IMAGING
The basic aims of imaging, in patients who have symptoms of stroke are 
 To  document  the  presence  or  absence  of  haemorrhage.  This 
information is critical as the treatment of the two vary.
 To determine the location and extend of brain damage.
 To assess the current and impending herniation.
 To exclude other entities, which may mimic stroke syndrome.
 To find out the cause of stroke.
Acute infarcts are more frequently visible on MRl than on CT scans. 
On admission approximately 90% of the MRI are positive compared to 60% 
in CT scans in acute infarcts.
 
COMPUTERISED TOMOGRAPHY OF ISCHAEMIC STROKE
The CT appearance of cerebral infarction is time dependent. Although 
the findings may be detected within 6 -8 hours of onset, CT may be normal up 
to 24 hours.
 Hyper acute infarct (less than 12 hours)
• Normal 50 -60%
• Hyper dense artery 25 -50%
• Obscuration of lentiform nuclei
 Acute (12 - 24 hours)
• Loss of grey white interfaces (insular ribbon sign, obscuration of 
cortex medullary white matter border)
• Low density basal ganglia.
• Sulcal effacement
1 – 3 days
• Increasing mass effect.
• Wedge shaped low-density area that involves both grey and white 
matter.
• Hemorrhagic transformation may occur.
 
 4 - 7 days
• Gyral enhancement
• Mass effect, edema persist.
 1 - 8 weeks
• Contrast enhancement persists.
• Mass effect resolves
 Months to years
• Encephalomalacic change
• Volume loss and
• Rarely calcification.
As mentioned above early finding on CT may be sudden loss of grey 
White  matter  contrast  and  effacement  of  adjacent  subarachnoid  spaces. 
However by 24 hours the abnormal low attenuating areas become obvious. 
Specifically insular ribbon sign has been defined as an early specific sign of 
MCA  infarction.  The  early  findings  on  noncontrast  CT  are  the  result  of 
development  of  cytotoxic  edema.  Occasionally CT scan through the  supra 
sellar cistern may show hyper dense MCA indicative of thrombus within the 
cytotoxic  and  vasogenic  edema.  Mass  effect  from  cytotoxic  edema  is 
maximum between 3 - 10 days, and may lead to herniation. Mass effect I 
completely resolves by 3 weeks.
Lacunar infarction -  These are secondary to arterial  disease affecting the 
deep penetrating vessels of the brain. These arteries may demonstrate tiny foci 
of stenosis caused by micro atheroma or lipohyalinosis. Because of the small 
size CT may miss the infarct.
TREATMENT OF ACUTE ISCHAEMIC STROKE
a. Early evaluation and supportive treatment.
b. Reperfusion strategies directed at arterial decimalization.
c. Cytoprotective strategies aimed at cellular and metabolic targets. 
Emergency care involves protection of the airway to avoid obstruction, 
hypoventilation and aspiration pneumonia. Care should be taken to prevent 
cerebral  edema  and  those  factors  which  exacerbate  it  like;  hypoxia, 
hyperthermia, hypercarbia, hypovolemia, and hypertension. If the patient 33 
develops cerebral edema it should be treated with mannitol (20%) solution 
Ig/kg over 30 min. bolus, followed by 0.25 - 0.5 gm/kg over 30 - 60 min 
every  4  -  6  hours,  maintenance  of  euvolemia  and  avoidance  of  glucose 
containing  solutions,  endotracheal  intubation  and mechanical  ventilation  if 
Glasgow coma scale is <8, hyperventilating to a PCO2 of 30 mm of Hg if the 
patient has herniation. 
During  the  first  few  hours  after  the  onset  of  symptoms  of  stroke, 
treatment  of  severe  hypertension  is  problematic,  because,  a  precipitous 
decline in arterial  pressure may cause harmful decrease in local perfusion. 
There is no evidence that antihypertensive therapy is beneficial in patients 
with stroke even above the Blood Pressure treatment thresholds recommended 
by various consensus panels – systolic > 200 to 220 mm of Hg, diastolic > 
110 to 120 mm of Hg. Therapy is indicated in patients with stroke who have 
aortic dissection, acute myocardial infarction, heart failure, acute renal failure 
or  hypertensive  encephalopathy;  and  for  patients  receiving  thromobolytic 
therapy in whom the systolic pressure is 180 mm of Hg higher or the diastolic 
pressure is 105 mm of Hg or higher. Precipitous decline in arterial perfusion 
may cause harmful decrease in local perfusion
 
THROMBOLYSIS
The use of thrombolytic agents in acute cerebral infarction has been 
studied extensively. Three early intravenous streptokinase trials were stopped 
because of higher death rate mainly due to intracerebral bleedings. 
The  European  Co-operative  Acute  Stroke  Study  (ECASS)  tested 
recombinant tissue plasminogen activator (rtPA - 1 mg/kg to 100mg max, 
10% as a bolus, then remainder over 60 min. IV) versus placebo in patients 
with  ischaemic  stroke  within  6  hours  of  onset  of  symptoms.  Overall 
thrombolysis was not beneficial because of excess of cerebral haemorrhage. 
However in those patients who had no signs of major infarction on initial CT 
scan, the functional outcome was improved.
The National Institute of Neurological Disorder and Stroke (NINDS) 
rtPA stroke study showed a clear benefit for rtPA in selected patients with 
acute stroke.  The NlNDS study used rtPA versus placebo in patients  with 
acute  ischaemic stroke within 3 hours  of onset.  Symptomatic intracerebral 
haemorrhage occurred in 6.4% patients on rtPA and 0.6% on placebo. There 
was a nonsignificant reduction in mortality and a significant absolute increase 
in number of patients with only minimal disability (32% placebo vs. 44% on 
rtPA). Thus despite increase in rate of ICH, treatment with IV rtPA within 3 
hours of onset of ischaemic stroke improved clinical outcome.
 
Finally ECASS II tested the NINDS dose of rtPA (0.9 mg/kg, max 
dose of 90 m) but allowed patients to receive drug up to 6 th hour as in ECASS 
I. No significant benefit was found.
Many hospitals have developed expert stroke teams to facilitate this 
treatment. The drug is now approved in the USA and Canada for acute stroke 
within  3  hours  of  onset  of  symptoms.  Two  recent  trials  (PROACT  and 
PROACT II) using intraarterial thrombolysis for acute MCA infarct showed 
benefit.
ANTITHROMBOTIC AND ANTIPLATELET DRUGS,
 Heparin - in the international stroke trial 19,435 patients with ischaemic 
stroke were randomly assigned to receive subcutaneous herparin at a dose 
of 5,000 to 12,500 IU twice daily or no heparin, with or without 300mg of 
aspirin per day, within 48 hours of onset  of symptoms. There were no 
differences among the  treatment groups in the primary  outcome (death 
within  14  days  or  dependency  at  6  months).  Among the  patients  who 
received heparin, there was a significant reduction (0.9%) in the absolute 
risk of recurrent ischemic stroke during the first 14 days, an effect that was 
counter balanced by a significant increase (0.8%) in the absolute risk of 
hemorrhagic stroke.
Kay Richard et al used low molecular weight heparin within 48 hours 
of onset of symptoms and found that there was significant improvement in the 
outcome at 6 months though others do not share this thought. A meta analysis 
of data from trials of early treatment with anticoagulant drugs for patients 
with acute ischaemic stroke suggest no clinical benefit with such treatment.
 Aspirin  -  aspirin  acts  by  irreversible  inhibition  of  platelet  function  by 
inactivation  of  cyclo-oxygenase.  International  stroke  trial  and  Chinese 
acute stroke trial showed that aspirin produces a small but real reduction 
of  about  10  deaths  or  recurrent  strokes  per  1,000 during  the  first  few 
weeks.  Both  trials  suggest  that  aspirin  should  be  started  as  soon  as 
possible after the onset of ischaemic stroke.
In  the  international  stroke  trial,  secondary  analysis  revealed  a 
significant decrease in the rate of recurrence of ischaemic stroke at two weeks 
among the patients treated with aspirin (2.8 vs. 3.9%) among those not treated 
with aspirin. However, there were no differences among the groups, in the 
combined end point of severe disability and death. Combined analysis of the 
results  of  the  lnternational  stroke  trial  and  the  Chinese  acute  stroke  trial 
suggest that early death, recurrent stroke or late death can be prevented in 1 
patient with acute stroke by giving aspirin to 100 patients with acute stroke.
 Cytoprotective  drugs  - The  recognition  of  penumbra  has  focused 
attention on the development of treatment to minimize or even reverse the 
damaging effects of ischaemic brain damage and such drugs are effective 
when they are started within a short period of time after the occlusion of 
the artery (therapeutic window).
Several groups of drugs have been tried. Calcium channel antagonists 
like  nicardipine,  nimodipine,  NMDA  receptor  antagonists  (Selfotel, 
Eliprodil),  ICAM  1  antibodies  (Enlimonab),  glutamate  antagonist 
(Lebeluzole), GABAergic antagonist (Diazepam, Clomethiozole), free radical 
scavengers  (Tirilazed,  dihydrolipoate),  inhibitors  of  lipid  peroxidation 
(Ebselen). Citicoline, intermediary in the biosynthesis of phosphatidyl choline 
was found to improve functional outcome when started within 24 hours of 
onset of stroke. 
Non-pharmacological therapy – Avoidance of atheroma risk factors as well 
as  life  style  modification  is  important  in  primary  and  secondary  stroke 
prevention.
Surgical therapy – Symptomatic carotid stenosis was studied in NASCET 
and  ESCT.  Both  showed  substantial  benefit  for  surgery  in  patients  with 
carotid stenosis of more than 70%. There was a 17% absolute reduction in the 
surgical group and 65% relative risk reduction favoring surgery. 
RELATED STUDIES:
1. Uric acid: an important antioxidant in acute ischaemic stroke 
W.S. WARING 
From the Clinical Pharmacology Unit and Research Centre, The University  
of Edinburgh, Western G eQ J Med 2002;
Free radical activity is characteristically increased in patients with any 
one of several major cardiovascular risk factors, and is thought to play a key 
role in the early development of atherosclerosis. As an antioxidant, Uric acid 
could be expected to confer protection against free radicals. In the context of 
acute ischaemic stroke, there is growing evidence to support a protective role 
for  Uric  acid. This  underpins  the  importance  of  oxidative  stress  in  the 
pathogenesis of  acute  stroke,  and  strengthens  the  rationale  for  further 
investigation of antioxidant treatments in this condition. The feasibility of Uric 
acid administration  to  temporarily  increase  circulating  concentrations has 
recently been established, and might allow its potential therapeutic impact to 
be examined in a clinical settingneral Hospital, Edinburgh, UK
2. Prognostic Significance of Uric Acid Serum Concentration in Patients 
With Acute Ischemic Stroke 
Angel  Chamorro,  MD;  Victor  Obach,  MD;  Álvaro  Cervera,  MD;  Marian 
Revilla, MD; Ramón Deulofeu, PhD John H. Aponte, MD© 2002 American 
Heart Association.
Increased uric acid values were found in men,  hypertensives, alcohol 
drinkers, and patients with coronary, pulmonary, or renal diseases. Diabetic 
patients  had  lower  uric acid  levels  on  admission.  In  patients  with  acute 
ischemic stroke, there is a 12% increase in the odds of good clinical outcome 
for  each milligram per  deciliter  increase  of  serum uric  acid.  This  finding 
reinforces the relevance of oxidative damage in ischemic stroke.
3. Prognostic Significance of Serum Uric Acid Concentration in Acute 
Stroke.Chakraborty  D,  Ghosh  S,  Guru  S,  Dash  LK,  Mohapatra  MK, 
Barik BKVSS Medical College, Burla, Orissa APICON 2009.
Diabetic patients had lower serum uric acid level on admission. Higher 
level of uric acid was found in patients with renal disease. Uric acid levels 
were directly associated with haematocrit, creatinine and triglyceride levels. 
Neurological impairment and the size of infarct on admission on CT scan was 
inversely associated. In patients with acute ischaemic stroke raised serum uric 
acid  level  was  associated  with  good  clinical  outcome  and  reinforces  the 
relevance of oxidative damage in stroke. 
4.Serum uric acid and brain ischemia in normal elderly adults
D. J. Schretlen, PhD, A. B. Inscore, PsyD, T. D. Vannorsdall, PhD, M. 
Kraut, MD, PhD, G. D. Pearlson, MD, B. Gordon, MD, PhD and H. A. 
Jinnah, MD, PhD. 2007 American Academy of Neurology.
In  this  cross-sectional,  observational  study,  we  examined the 
relationship between serum Uric acid and aggregate volume of white matter 
hyperintense  (WMH) signals  observed on proton density and T2-weighted 
brain MR images in a community sample of 177 adults ages 20 to 92. Using 
logistic  regression,  we  tested  whether participants  with  Uric  acid 
concentrations in the highest quartile of the sample—but still normal—would 
have  increased WMH  volumes.  These  findings  demonstrate  that  mildly 
elevated serum  uric  acid  is  associated  with  increased  burden  of  cerebral 
ischemic  pathology,  particularly  in  older  adults.  We  outline  the  potential 
pathogenesis of this association
5. Blood Markers for the Prognosis of Ischemic Stroke
William Whiteley, BM BCh, MRCP; Wei Li Chong, BM BCh; Anshuman 
Sengupta, BM BCh Peter Sandercock, MD, FRCP  © 2009 American Heart 
Association.
We searched Medline and EMBASE from 1966 to January  2007 for 
studies of blood markers in patients with ischemic stroke and an assessment of 
outcome  (death,  disability,  or  handicap). We adopted  several  strategies  to 
reduce bias.
6. Uric acid provides an antioxidant defense in humans against oxidant- 
and  radical-caused  aging.  Bruce  N.  Ames,  Richard  Cathcart, 
Elizabeth Schwiers, and Paul Hochsteint
Urate  is  about  as  effective  an  antioxidant  as  ascorbate  in  these 
experiments. Urate is much more easily oxidized than deoxynucleosides 
by singlet oxygen and is destroyed by hydroxyl radicals at a comparable 
rate.  The  plasma  urate  levels  in  humans  (about  300  microM)  is 
considerably higher than the ascorbate level, making it one of the major 
antioxidants in human.
7.  A  Pilot  Study  of  Dual  Treatment  With  Recombinant  Tissue 
Plasminogen Activator and Uric Acid in Acute Ischemic Stroke
Sergio  Amaro,  MD;  Dolors  Soy,  PhD;  Víctor  Obach,  MD;  Álvaro 
Cervera,  MD,  PhD;  Anna  M.  Planas,  PhD  Ángel  Chamorro,  MD,  PhD
© 2007 American Heart Association
 A  very  early  assessment  of  the  levels  of  Uric  acid allowed  the 
identification of a rapid reduction of  Uric acid after stroke only in untreated 
patients, which was maximal 6 hours after the onset of symptoms. The study 
also showed lower lipid peroxidation at follow up in patients allocated the 
high-dose  of  Uric  acid.  These  findings  accord  with  acute stroke  studies 
describing a progressive decline of intracellular and extracellular antioxidants 
such as superoxide dismutase, carotenoids, or vitamin E. A fall of antioxidant 
vitamins in plasma has also been associated with increased oxidative stress 
and worse stroke outcome Yet, the early consumption of Uric acid observed in 
untreated patients, the effect  on lipid peroxidation,  and the lack of serious 
adverse effects  support  additional  clinical  assessment  of  Uric  acid 
administration in  acute  stroke.  The  low cost  of  Uric  acid is  an  additional 
bonus for a larger trial because even a mild clinical benefit would be  cost-
effective.
8.Antioxidant  Profile  and  Early  Outcome  in  Stroke  Patients  Antonio 
Cherubini,  MD; Maria Cristina Polidori,  MD; Mario Bregnocchi, 
MD; Salvatore Pezzuto, MD; Roberta Cecchetti, BS; 2000 American 
Heart Association
In conclusion, our longitudinal study of antioxidant levels  during the 
first week after acute ischemic stroke reveals that  almost all antioxidants are 
reduced immediately after a cerebrovascular accident and increase over the 
following days, suggesting the presence of a condition of oxidative stress in 
this  setting. Furthermore,  the finding of  a relationship between antioxidant 
profile and early outcome of the cerebral infarct might provide new insights 
into  the  pathogenesis  of  ischemic  stroke  as  well as  open  new therapeutic 
possibilities.
9.Fluorescent  histochemical  localization  of  lipid  peroxidation  during 
brain reperfusion following cardiac arrest.White BC,  Daya A,  DeGracia 
DJ, O'Neil BJ, Skjaerlund JM, Trumble S, Krause GS, Rafols JA.
These observations indicate that neurons in the selectively vulnerable 
zones of the cortex and hippocampus are early and specific targets of lipid 
peroxidation during post-ischemic reperfusion.
10. Uric acid reduces exercise-induced oxidative stress in healthy adults
W. S. WARING, A. CONVERY, V. MISHRA, A. SHENKIN, D. J. WEBB* 
and S. R. J. MAXWELL
Uric acid administration abolished the exercise-induced elevation of 
plasma  8-iso-PGF2a concentrations.  High  Uric  acid concentrations  are 
associated with increased serum antioxidant capacity and reduced oxidative 
stress  during  acute  physical  exercise  in  healthy  subjects.  These  findings 
indicate  that  the  antioxidant  properties  of  Uric  acid are  of  biological 
importance in vivo
11. Antioxidant capacity after acute ischaemic stroke S.E. GARIBALLA, 
T.P. HUTCHIN1 and A.J. SINCLAIR1© 2002 Association of 
Physicians
Experimental studies have reported a rapid increase in the production 
of markers of oxidative damage following acute stroke due to the reperfusion 
event  following  ischaemia, and  that  endogenous  antioxidant  defences  are 
rapidly depleted, permitting further tissue damage  Ryan et al. have previously 
reported that in healthy subjects, TAC measured by ECL is almost completely 
accounted for  by  uric acid.  Uric  acid,  which is  the  end product  of  purine 
metabolism, has long been regarded as a  potent  endogenous water-soluble 
antioxidant and radical scavenger in humans.However, its  therapuetic benefit 
in  diseases  in  which  free  radicals  are  thought  to  be  involved is  yet  to  be 
proven.
12. Uric acid administration for neuroprotection in patients with acute 
brain ischemia References and further reading may be available for 
this article.  To view references and further reading you must   this 
article.
Angel  Chamorro,  Anna  M.  Planas,  Dolors  Soy  Muner  and  Ramon 
Deulofeu
Uric  acid  is  the  end product  of  purine  metabolism and  a  powerful 
water-soluble antioxidant and radical scavenger in humans whose generation 
is increased in situations of oxidative stress, such as brain ischemia. Although 
hyperuricemia has been related to an increased risk of cardiovascular events, 
the association was not found significant in many studies after adjustment for 
the effect of confonders. We hypothesize that the administration of uric acid 
could be beneficial and cost effective in patients sustaining acute oxidative 
stress, such as those with acute ischemic stroke. Uric acid could also extend to 
more than 3 h the therapeutic window of rt-PA after stroke.
13.  The  Continued  Yin  and Yang of  Uric  AcidJesse  Dawson,  MRCP; 
Terry Quinn, MRCP; Kennedy Lees, MD, FRCP Matthew Walters, 
MD, FRCP © 2008 American Heart Association,
The "positive" effect  of  Uric acid claimed by Amaro et  al  must be 
balanced against established data suggesting a link between increasing  serum 
Uric acid and cardiovascular disease This relationship remains true for the 
acute  infarct  period  We  have  previously shown. that  small  increments  in 
admission  serum  Uric  acid are  associated with  significantly  worse  90-day 
outcome.  However,  their  group have  previously  suggested  very  different 
findings—that increasing  serum  Uric  acid is  associated  with  favorable 
outcome at 7 days.

MATERIALS AND METHODS
SETTING:
                 The study on “the correlation between the levels of serum uric acid  
and the prognosis of acute ischemic stroke” was carried out in the Department 
of   Medicine,  Madurai  Medical  College  and Government  Rajaji  Hospital, 
Madurai
COLLABORATIVE DEPARTMENTS:
Department of Biochemistry, Neurology, Radiology, Madurai Medical 
College, Madurai
STUDY  DESIGN: prospective  study  of  consecutive  patients  with  acute 
stroke admitted to Government Rajaji Hospital, Madurai.
PERIOD OF STUDY: OCTOBER 2008 TO SEPTEMBER 2009
SAMPLE SIZE:
Patients were classified into ischemic stroke or primary haemorrhage. 
CT scan of brain was required for the diagnosis of ischemic stroke. Patients 
without neuroimaging were classified as having as uncertain stroke type were 
excluded in statistical analysis. 50 Patients were included in this study.
DEFINITIONS:
Acute stroke is defined as “rapidly developing clinical signs of focal 
and global disturbance of cerebral function with symptoms lasting 24 hours or 
longer or leading to death, with no apparent cause other than vascular origin” 
according to WHO criteria.
        Hypertension was defined as a previous record of atleast 2 recordings 
above  140/90 mmHg or  requirement  of  regular  intake  of  antihypertensive 
drugs.
        Diabetes was defined as having a fasting plasma glucose of >126 mg/dl, 
postprandial  plasma  glucose>200mg/dl  or  requirement  of  regular 
hypoglycemic drug intake.
Arm Impairment-inability  to  feed,  dress  without  assistance  of  other 
person/mechanical  device.  Leg  impairment-inability  to  walk  without  help 
from  other  person/mechanical  device.  Speech  impairment-inability  to 
communicate in unfamiliar situations
FUNCTIONAL OUTCOME:
Grade 1-neurosymptoms no signs or impairment
Grade 2-between 1 and 2
Grade 3-symptoms + signs without impairment
Grade 4-impairment of 1 limb or speech
Grade 5-between 4 and 6
Grade 6-impairment in 2 limbs and speech or death
DYSLIPIDEMIA:
Fasting lipid profile was done in all patients
The cut-off values of each class of lipids were taken as abnormal as follows:
Total cholesterol  > 200mg/dl
HDL cholesterol   < 40 mg/dl
LDL cholesterol   >130 mg/dl
Triglyceride         >150 mg/dl
INCLUSION CRITERIA:
1.All acute ischemic stroke within 24 hours of onset
EXCLUSION CRITERIA
1.Haemorrhagic stroke
2.Ischaemic stroke >24 hours from onset
3.CNS tumours
4.Vasculitic stroke
5.CNS infections
6.Patients who did not do CT-SCAN
7.Subdural hematoma
ETHICAL CLEARANCE:
Necessary  ethical  clearance  was  obtained  from  ethical  committee, 
Government Rajaji Hospital, Madurai.
METHODS
After  obtaining  the  verbal  consent  either  from  the  patient  or  the 
relatives,  all  patients  were  evaluated  by  complete  medical  history,  full 
neurological examination, standardized blood tests imaging studies and data 
was recorded in a standardized sheet
Clinical history was obtained from the patient, his/her relatives or past 
records.  History  regarding  diabetic  status,  hypertension,  TIA,  smoking, 
alcoholism, chronic kidney diseases.
Clinical examination was done to assess the side of the stroke, glasgow 
coma scale on admission, presence of gaze palsy ,  papillary abnormality , 
plantar reflex  facial palsy, speech difficulty, admission blood pressure.
Electrocardiography, blood sugar, urea, creatinine, lipid profile , serum 
uric acid and CT-brain were done after admission.
          The functional outcome at the time of discharge was noted. If the 
patient  was  discharged  against  medical  advice  in  the  terminal  stage  was 
recorded as a bad outcome. All relevant data were fed into a computer and 
results were calculated.
   
Statistical Tools (To be included at the end of Materials and Methods)
The  information  collected  regarding  all  the  selected  cases  were 
recorded in a Master Chart. Data analysis was done with the help of computer 
using Epidemiological Information Package (EPI 2008).
Using this software range, frequencies, percentages, means, standard 
deviations, chi square and   'p'   values were calculated. Kruskul Wallis chi-
square   test  was  used  to  test  the  significance  of  difference  between 
quantitative variables and Yate’s test for qualitative variables. A 'p' value less 
than 0.05 is taken to denote significant relationship.
LIMITATIONS OF THE STUDY:
1.  The  number  of  patients  evaluated  had  been  small  and  this  could  have 
influenced the results of the study.
2.11 patients did not take CT scan due to various reasons among 61 patients 
studied  and  hence  their  data  could  not  be  entered  into  ischemic  or 
haemorrhagic stroke category.
3. Large samples could not be entered into the study because most of the 
patients admitted after 24 hours of onset of stroke.
RESULTS AND ANALYSIS
AGE DISTRIBUTION
50%
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RESULTS AND OBSERVATIONS
A : CHARACTERISTICS  OF  CASES  STUDIED
Table 1 : Age distribution
AGE GROUP
CASES
No. %
Upto 40 years 3 6
41-50 years 5 10
51 – 60 years 25 50
> 60 years 17 34
Total 50 100
Range
Mean
S.D.
32 – 72 years
57.6 years
 9.0 years
 
SEX
34%
66%
MALE FEMALE
Table 2
Sex
Sex
CASES
No. %
Male 33 66
Female 17 34
Total 50 100
BMI & BLOOD SUGAR VALUES
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Table 3
Quantitative parameters
Parameter
Normal cases Abnormal 
cases Range Mean S.D.
No. % No. %
B.M.I 12 24 38 76 20.6-29.2 25.6 1.6
Blood Sugar 32 64 18 36 60-260 134.1 57
HISTORY
27
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Table 4
Duration of Stay
Parameter Range Mean S.D.
Duration of Stay 4.8-13.2 9.96 1.81
Table 5
History
Parameter
Yes No
No. % No. %
Smoking 27 54 23 46
D.M. 11 22 39 78
Hyper Tension 18 36 32 64
INVESTIGATIONS
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Table 6
Investigations
Investigations
Positive Negative
No. % No. %
Renal  Function  Test 
Abnormality
11 22 39 78
Dyslipidemia 27 54 23 46
URIC ACID LEVELS
8%
12%
16%
24%
22%
18%
Upto 3.1 3.2 - 4.2 4.3 - 5.2 5.3 - 6.2 6.2 - 7.2 > 7.2
Table 7
Uric Acid 
Uric Acid 
CASES
No. %
Upto 3.1 4 8
3.2 – 4.2 6 12
4.3-5.2 8 16
5.3-6.2 12 24
6.3-7.2 11 22
> 7.2 9 18
Total 50 100
Range 2.3-11.3
Mean 5.9
S.D. 2.0
C T FINDINGS
46%
54%
SMALL INFARCT LARGE INFARCT
Table 8
C.T.Findings
C.T. Findings
Cases
No. %
< 6 = Small infarct 27 54
> 6 Large infarct 23 46
Total 50 100
FINAL OUTCOME
14%
28%
22%
8%
22%
6%
Grade 1 Grade 2 Grade 3 Grade 4 Grade 5 Grade 6
Table 9
Final Outcome
Final Outcome
Cases
No. %
Grade 1
Grade 2
Grade 3
               Good Prognosis Total
11
4
14
29
22
8
28
58
Grade 4
Grade 5
Grade 6
             Bad Prognosis Total
11
3
7
21
22
6
14
42
Total 50 100
AGE AND URIC ACID
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B : RELATIONSHIP BETWEEN  URIC ACID LEVELS & OTHER 
PARAMETERS
Table 10
Age and Uric Acid levels
Age Group
Uric Acid
Mean S.D.
Upto 40 years 5.83 1.73
41-50 5.86 2.12
51-60 6.13 2.16
> 60 years 5.59 1.83
‘p’ 0.8393
Not Significant
The age of this study group was not significantly correlated with serum 
uric acid level
Table 11
Sex and Uric Acid levels
Sex
Uric Acid
Mean S.D.
Male 6.04 2.24
Female 5.65 1.39
‘p’ 0.6873
Not Significant
The sex of this study group was not significantly correlated with serum 
uric acid.
Table 12
B.M.I. and Uric Acid levels
B.M.I.
Uric Acid
Mean S.D.
Upto 25 5.64 2.01
> 25 5.79 2.0
‘p’ 0.5318
Not Significant
The  BMI of  this  study  group  was  not  significantly  correlated  with 
serum uric acid.
Table 13
Blood Sugar and Uric Acid levels
Blood Sugar
Uric Acid
Mean S.D.
Normal (Upto 140) 6.1 2.09
Abnormal (Above 140) 5.56 1.8
‘p’ 0.3315
Not Significant
The Blood sugar of this study group was not significantly correlated 
with serum uric acid level.
Table 14
Past History and Uric Acid levels
History of
Uric acid level of cases
‘p’
Yes No
Mean S.D. Mean S.D.
Smoking 6.06 2.39 5.7 1.4 0.9612
Not Significant
D.M. 4.61 1.19 6.37 2.03 0.0065
Significant
H.T. 6.2 2.44 5.74 1.71 0.6332
Not Significant
The  history  of  smoking  and  alcohol  of  this  study  group  was  not 
significantly correlated with serum uric acid level. But the history of diabetes 
was significantly associated with serum uric acid level.
Table 15
Other Investigation results and Uric Acid levels
Investigations
Uric acid level of cases
‘p’
Positive Negative
Mean S.D. Mean S.D.
Renal Function Test 5.93 2.28 5.9 1.93 0.8789
Not 
Significant
Lipid Profile 5.41 1.43 6.49 2.4 0.07
Not 
Significant
The renal function test and lipid profile abnormality of this study group 
was not significant correlated with serum uric acid level. 
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Table 16
C.T. Findings and Uric Acid levels
C.T. Findings
Uric Acid
Mean S.D.
Good Prognosis- < 6 7.17 1.64
Bad Prognosis - > 6 4.41 1.14
‘p’ 0.0001 
 Significant
The CT Brain finding in this study group was significantly correlated 
with serum uric acid level in the form of small sized infarcts in patients with 
raised serum uric acid.
 
FINAL OUTCOME AND URIC ACID
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Table 17
Uric Acid levels and Final Outcome
Final Outcome Uric Acid
Mean S.D.
Grade 1 7.55 1.71
Grade 2 6.1 0.86
Grade 3 6.92 1.71
Grade 4 4.64 1.29
Grade 5 3.97 1.18
Grade 6 4.0 1.04
‘p’ 0.0001
 Significant
The  functional  outcome  of  this  study  group  was  significantly 
correlated with serum uric acid level in the form of better immediate outcome 
in patients with raised serum uric acid.
DISCUSSION
50  cases  of  acute  ischemic  stroke  within  24  hours  of  onset  were 
admitted  in  the  department  of  Medicine,  Madurai  Medical  College  and 
Government Rajaji Hospital during the period of October 2008 to May 2009.
  
Among total  number stroke patients  50 patients  who underwent CT 
scan, and they were included in the statistical analysis. All the 50 patients 
were found to have ischemic stroke.
1. AGE DISTRIBUTION:
The total number of cases were 50. Maximum number of cases were 
seen in the age group between 51-70 years. The youngest patient was 34 years 
and the oldest patient was 72 years. This correlates with study by Daga et al32. 
There was no significant correlation between the age of onset of stroke and 
serum uric acid levels.
2. SEX DISTRIBUTION:
There were 33 male patients and 17 female patients. This observation 
correlates with Daga et al32.  There is no significant difference in uric acid 
level with regard to sex.
3. RISK FACTORS IN STROKE:
In the present study,
36% of cases were hypertensives. There was no significant correlation 
between Hypertension and serum uric acid level even though following study 
shows significant correlation.
Strong epidemiological data have linked uric acid to hypertension in 
humans  (cannon et  al,  1966,  Kinsey  et  al,  1961;  and Klien  et  al,  1973)17 
experimental  animal  data  suggests  hyperuricemia  causes  hypertension 
(Mazzali  et  al,2001:  Sanchez  et  al,  2002;  and Watanabe,  2002)33.  Olivetti 
heart  study  (Jossa  et  al,  1994)21 had  shown  an  independent  positive 
association between serum uric acid and the development of hypertension.
In the present study there is  no significant correlation between uric 
acid level and hypertension.
DIABETES MELLITUS:
In our study 22% of patients had diabetes.
In  this  study,  Prognostic  Significance  of  Uric  acid  Serum 
Concentration in Patients With Acute Ischemic Stroke by Angel Chamorro, 
MD; Victor Obach, MD; Alvaro Cervera, MD; Marian Revilla, MD; Ramón 
Deulofeu, PhD John H. Aponte, MD, shows that increased Uric acid values 
were  found  in  men, hypertensives,  alcohol  drinkers,  and  patients  with 
coronary, pulmonary, or renal diseases. Diabetic patients had lower uric acid 
levels  on  admission.  Uric  acid  was  directly  associated with  hematocrit 
(P=0.001),  sodium  (P=0.001),  creatinine  (P=0.001), and  triglycerides 
(P=0.001)  and  inversely  related  with  nonfasting glucose  (P=0.001)  levels. 
Neurological impairment on admission (P=0.001) and final infarction size on 
CT/MRI (P=0.01) were also inversely associated with uric acid.  A logistic 
regression adjusted  for  confounders  confirmed  the  following  independent 
(odds  ratio,  95%  CI)  good  outcome  predictors:  age  (0.97,  0.96 to  0.99), 
Mathew score on admission (1.14, 1.12 to 1.17),  erythrocyte sedimentation 
rate (0.98, 0.97 to 0.99), infarction volume (0.98, 0.98 to 0.99), and uric acid 
(1.12, 1.00 to 1.25)  Di Yi Jun Yi Da Xue Xue Bao. 2002 Jan;22(1):70-1.
Even though Canon et al17 showed a prevalence of hyperuricemia in 
25% of long standing uncontrolled diabetes mellitus. Our study did not show 
correlation between serum uric acid level and diabetes was not significant.
BMI:
A large body of evidence links uric acid with metabolic syndrome of 
insulin  resistance,  obesity,  hypertension,  and  dyslipidemia.  In  this  study 
relationship between obesity, hypertension, dyslipidemia, and hyperuricemia 
was statistically not significant. 
Cappcio et  al  (1998)  reported an association of  hyperuricemia with 
increased  tubular  reabsorption  of  sodium,  thus  providing  a  link  with 
hyperuricemia, hypertension and hyperinsulinemia. 
The mean uric acid in those subjects with BMI>25 were higher than 
those with BMI< 25 and the difference was statistically significant.  Shoba 
kelker et al, Healey et al, (1973)34 observed a significant correlation between 
serum uric acid and obesity.
But in contrast to the above mentioned studies our study did not show 
any  correlation  between  various  components  of  metabolic  syndrome  and 
serum uric acid.
DYSLIPIDEMIA:
Elevated triglycerides  is the most important risk factor in acceleration 
of atherosclerosis according to vnitr lek (1990).
According to Cadeddu et al, (1983) in their study of hyperuricemia and 
cardiac  risk  factors  there  was  strict  correlation  of  hyperuricemia  and 
dyslipidemia.
Bouvenot G et at (1986)16 also showed the relationship between serum 
uric  acid  and  dyslipidemia.  In  the  present  study  the  relationship  between 
serum uric acid and dyslipidemia was not significant.
SMOKING:
There  were  no  current  studies  regarding  the  correlation  between 
smoking and serum uric acid in stroke patients.
URIC ACID:
Despite  the  widely  held  view  that  elevated  serum Uric  acid 
concentrations confer  increased  risk  of  atherosclerotic  disease,  there  is  no 
compelling  biological  evidence  of  a  causal  link.  Free  radical activity  is 
characteristically  increased  in patients  with  any one  of  several  major 
cardiovascular  risk  factors,  and is  thought to  play  a  key  role  in the  early 
development  of  atherosclerosis. As  an  antioxidant,  Uric  acid  could  be 
expected to confer  protection against  free  radicals.  In the  context  of acute 
ischaemic  stroke1, there is growing evidence to support a protective role for 
Uric  acid. This  underpins  the  importance  of  oxidative  stress  in the 
pathogenesis of  acute  stroke,  and  strengthens  the  rationale  for  further 
investigation of antioxidant treatments in this condition. The feasibility of Uric 
acid  administration  to  temporarily  increase  circulating  concentrations has 
recently been established,15 and might allow its potential therapeutic impact to 
be examined in a clinical setting. Ongoing basic research is likely to shed new 
light on the cardiovascular effects of Uric acid, and will hopefully allow the 
significance of serum concentrations to be interpreted more clearly
In this study 80% of the patients had elevated uric acid level. In this 
study we found that significant association of serum uric acid with functional 
outcome.(those who had high uric acid level at the time of admission had 
good final outcome).
  
In  this  study we found significant  association  between the  level  of 
serum uric acid and infarct size in CT brain (those who had high serum uric 
acid at the time of admission had small infarct in CT-brain).
 A recent study2 lends support to this hypothesis  in a clinical setting. 
Serum Uric acid concentrations measured in 881 consecutive ischaemic stroke 
patients at the onset of ischaemic symptoms were found to correlate inversely 
with  early  neurological  impairment and  final  infarction  size  on  computed 
tomography or magnetic resonance imaging. Additionally,  serum Uric acid 
concentrations  were positively  associated  with  a  good  clinical  outcome  at 
hospital discharge  (Matthew  score  of  >75),  where  each  mg/dl  Uric  acid 
increase (equivalent  to  60  µmol/l;  reference  range  120–420 µmol/l)  was 
associated with a 12% increase  in the odds of a good outcome. Importantly, 
these relationships were independent of potential confounders, including age, 
diuretic  use,  renal function  or  the  presence  of  major  cardiovascular  risk 
factors. This is the first study to characterize the relationship between  serum 
Uric acid concentration and neurological severity of acute ischemic  stroke in a 
large series of patients
In the study by Chakraborty D, Ghosh S, Guru S, Dash LK, Mohapatra 
MK, Barik BK VSS Medical College, Burla, Orissa APICON 2009 3. Uric 
acid  levels  were  directly  associated  with  haematocrit,  creatinine  and 
triglyceride  levels.  Neurological  impairment  and  the  size  of  infarct  on 
admission on CT scan was inversely associated with serum uric acid levels. In 
patients  with  acute  ischemic  stroke  raised  serum  uric  acid  level  was 
associated  with  good  clinical  outcome  and  reinforces  the  relevance  of 
oxidative damage in stroke.
CONCLUSION
The following conclusions were derived from the study.
1. The serum Uric acid was independent of age, sex, BMI, hypertension, 
diabetes, smoking, dyslipidemia and renal parameters.
2. Outcome in patients with acute ischemic stroke was better in patients 
with high serum uric acid level in terms of higher function recovery, 
motor activity, self – care, small size infart etc.
3. Every 1mg increase in Uric acid above 4.2mg /dl was associated with 
better outcome.
4. The  antioxidant  capacity  of  serum  Uric  acid  is  a  favourable 
independent factor that improves the clinical prognosis of patients with 
acute ischemic stroke.
5. This  study opens up the  possibility  of  therapeutic  administration of 
Intravenous  infusion  of  uric  acid  along  with  rtPA  to  improve  the 
immediate prognosis of acute ischemic stroke.
SUMMARY
This  study  “CORRELATION  BETWEEN  SERUM  URIC  ACID 
LEVEL AND THE PROGNOSIS OF ACUTE ISCHEMIC STROKE” was 
carried out in Govt.Rajaji Hospital, Madurai Medical college, Madurai from 
October 2008 to September 2009.
 50  cases  of  acute  ischemic  stroke  within  24  hours  of  onset  were 
admitted in this period. Male out numbered stroke. Males - 66%, females- 
34%. 
The risk factors in this study group were increasing age, hypertension, 
smoking, diabetes, dyslipidemia.
Raised  serum uric  acid associated  with small  size  infarct  and good 
functional outcome at the time of discharge.
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PROFORMA
  
NAME:                                             AGE:                                 SEX:
 
I.P.NO: 
OCCUPATION:                               WARD:
BMI:                                             
HISTORY:
1.HYPERTENSION:                YES/NO
   REGULAR TREATMENT:  YES/NO    
2.DIABETES           :                YES/NO
   REGULAR  TREATMENT: YES/NO
3.SMOKING  :                         YES/NO
4.DURATION  OF STAY          :
VITAL SIGNS:
PR-                                   BP-
EXAMINATION                                            
1.TIME OF PRESENTATION AFTER STROKE:
2.CVA                                                                    : RIGHT/LEFT
3.HANDEDNESS                                                  : RIGHT/LEFT
4.LEVEL OF CONSCIOUSNESS                         :  
5.LANGUAGE                                                       :
6.CRANIAL NERVES                                           :
7.MOTOR SYSTEM                                              :
8.SENSORY SYSTEM                                           :
9.CEREBELLUM                                                   :
10.AUTONOMOUS NERVOUS SYSTEM           :
11.FINAL OUTCOME ON DISCHARGE             :
INVESTIGATIONS :
BLOOD SUGAR                  :
NORMAL RENAL PARAMETERS     : YES/NO
URIC ACID         :
DYSLIPIDEMIA                                     :YES/NO
CT-BRAIN : INFARCT SIZE: 
